Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: AGE 12 TO 45 YEARS OF AGE PATIENTS PRESENTING WITH COMPLAINTS OF PAPULES,PUSTULES AND NODULES PATIENTS WILLING TO PARTICIPATE PATIENTS WILLING TO GIVE INFORMED AND WRITTEN CONSENT
Exclusion criteria
Exclusion criteria: Age less than 12 years and greater than 45 years of age Grade 1 and 4 acne Irregular cycles Liver Dysfunction Renal Dysfunction Hypersensitivity Pregnancy Planning for pregnancy Breastfeeding Patients who were treated recently with anti acne medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcome would be reduction in the number of papules,pustules and nodules.Timepoint: It will be assessed at the initial visit,then after 2 weeks when patient comes for follow up and then after 4 weeks which is the final visit, all of which will be completed on 24th february 2021. | — |
Secondary
| Measure | Time frame |
|---|---|
| Using this study,we can also assess if there are occurrence of any new side effects of the drug Lymecycline,at 1 week and 3 weeks durationTimepoint: The effect of the Lymecycline and Doxycycline on the acne lesions at 1 week and 3 weeks can also be assessed.We can also see for drug interactions,complications at 1 week and 3 weeks of giving the drug. | — |
Countries
India
Contacts
Chettinad Hospital and Research Institute